EV : Analysis & Opinions

  • Showing 1-100 of 117 items
  • 1
  • 2
  • >>
  1. Healthways-TAL to Improve Well-Being Solutions in Australia - ...

    December 18, 2014
    Healthways Inc. (HWAY) recently entered into a partnership with Australia's specialty life insurer TAL to jointly provide ...
  2. Air Methods: A Strong Sell on Weak Q3 & Estimate Revision - Analyst ...

    December 17, 2014
    On Dec 17, 2014, Zacks Investment Research downgraded medical services provider Air Methods Corp (AIRM) to a Zacks Rank #5 ...
  3. ICON (ICLR) Now a Strong Buy: Should It Be in Your Portfolio? ...

    December 16, 2014
    ICON has been witnessing rising earnings estimates on the back of a new FDA project and an increased guidance for fiscal ...
  4. CNH Industrial, Evogene Subsidiary Extend Collaboration - Analyst ...

    December 16, 2014
    CNH Industrial (CNHI) extended its Latin American unit's collaboration with Evofuel, a wholly-owned subsidiary of leading ...
  5. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  6. These New Dividend Payers Yield Up To 7%

    August 11, 2014
    Companies that have recently declared their first-ever dividend may be one of the best investing barometers in existence. ...
  7. These New Dividend Payers Yield Up To 9.4%

    August 11, 2014
    Companies that have recently declared their first-ever dividend may be one of the best investing barometers in existence. ...
  8. 5 Drug Companies Profiting From Generics

    August 4, 2014
    Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better-than-expected earnings last week and raised its ...
  9. Think Small Banks For Big Profits

    April 25, 2014
    The banking industry avoided the attention of activists, for the most part, as the industry was still recovering from the ...
  10. Alternative Energy Stock Outlook - Feb 2014 - Industry Outlook

    February 4, 2014
    Alternative Energy Stock Outlook - Feb 2014 - Industry Outlook
  11. After years of struggling, Europe may finally be turning a corner. We'll take a look at how you can profit from the turnaround.

    Believe It Or Not, European Stocks Are Heating Up

    October 24, 2013
    After years of struggling, Europe may finally be turning a corner. Critical pieces of economic data are all pointing towards ...
  12. Akorn Scores A Rare Win-Win Acquisition

    August 27, 2013
    Akorn builds value by buying Hi-Tech
  13. Red Hat And Other Software Stocks That May Beat Revenue Estimates ...

    August 22, 2013
    Analysts at Lazard believe software makers Citrix Systems (NASDAQ: RHT) are well positioned to benefit from strong government ...
  14. Veolia Offers A Decent Dividend, But Both Uncertainty And Upside

    August 20, 2013
    Veolia has more self-improvement work ahead, but leverage to an improving Europe could create upside
  15. Estee Lauder Delivers A Beautiful Q4: Should You Buy?

    August 20, 2013
    Estee Lauder (EL) delivered beautiful Q4 earnings August 15 on a day when the Dow lost 225 points due to Wal-Mart's (WMT) ...
  16. Noah Holdings Jumps 42% Over Two Days--Time To Sell?

    August 15, 2013
    Chinese wealth management company Noah Holdings (NYSE:NOAH) saw its stock jump 42% in the two days since August 8 when it ...
  17. Novo Nordisk Getting Its Trial By Fire

    August 8, 2013
    Novo Nordisk is facing more challenges than it has in a while, but the growth remains strong.
  18. Does Amgen Deserve To Be Part Of The Biotech Bull Run?

    July 31, 2013
    Amgen is beating growth targets today, but fears about generics and a dull pipeline concern investors.
  19. Pfizer Gives Up Stake in Zoetis - Analyst Blog

    June 25, 2013
    Pfizer lowered its outlook for 2013 to reflect the impact of the divestment of the remaining stake in Zoetis.
  20. OPTT to Employ PDS for Seabed Survey - Analyst Blog

    June 25, 2013
    Ocean Power engages Victoria-based Professional Diving Services to carry out seabed surveys for its proposed wave energy ...
  21. Alternative Energy Stock Outlook - June 2013 - Industry Outlook

    June 7, 2013
    Alternative Energy Stock Outlook - June 2013 - Industry Outlook
  22. Explosive Stocks Under $10 - Screen of the Week

    June 4, 2013
    Explosive Stocks Under $10 - Screen of the Week
  23. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    May 9, 2013
    Teva's partnership with Alexza looks like an expensive gamble.
  24. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  25. Teva Still Too Cheap, But Still Too Uncertain

    May 3, 2013
    Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
  26. Natural Gas: A Big Win For Israel And Its Producers

    April 2, 2013
    While it’s a tech powerhouse, the natural gas game is quickly changing Israel’s economy for the good. The recent prolific ...
  27. The State of the Union Address for Investors - Analyst Blog

    February 13, 2013
    Here is my short-form take on President Obama's State of the Union address.  This is written to outline four major areas ...
  28. Can ServiceSource Turn It Around?

    February 11, 2013
    ServiceSource has to prove to the Street that it has a viable long-term model.
  29. MedTech Industry Stock Outlook - Jan 2013 - Zacks Analyst Interviews

    January 29, 2013
    We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide ...
  30. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust pipeline. The ...
  31. Revealed: StreetAuthority's Best Stock Picks of 2012

    January 7, 2013
    Last Monday, I asked each of the StreetAuthority stock market strategists to put into writing their assessments of the year ...
  32. Impax Launches Opana ER Generic - Analyst Blog

    January 7, 2013
    Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, recently ...
  33. Mondelez International Among Consumer/Non-Cyclical's Biggest ...

    December 10, 2012
    The market has been doing well after the morning's trading. The Nasdaq has risen 0.6%; the S&P 500 is up 0.2%; and the ...
  34. Early Research Calls

    November 28, 2012
    New York, May 10th (TradersHuddle.com) - Research Analyst's early calls ahead of the bell. Prudential (NYSE:PRU) was upgraded ...
  35. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  36. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  37. Stock Market News for October 26, 2012 - Market News

    October 26, 2012
    Benchmarks added paltry gains following a batch of mixed earnings releases and positive domestic and international economic ...
  38. Dean Foods To Spin Off White Wave

    October 18, 2012
    The pricing of Dean Foods put a fire under its stock price, sending it up more than 10% for the day. Its theoretical value ...
  39. New Ratings

    October 9, 2012
    New York, May 23rd (TradersHuddle.com) - These are the research analyst new ratings before the market open. Travelers (NYSE:TRV) ...
  40. Continental Resources and More Big Movers in Oil and Gas Operations ...

    September 24, 2012
    The morning has been bad for the market. The Nasdaq is trading down 0.7%; the S&P 500 has fallen 0.2%; and the Dow has ...
  41. Philip Morris and Other Consumer/Non-Cyclical Stocks Making Big ...

    September 13, 2012
    The market is on the rise this morning. The Nasdaq has moved up 0.3%; the S&P 500 is trading up 0.1%; and the Dow has ...
  42. Shire Settles Patent Dispute - Analyst Blog

    September 12, 2012
    Shire LLC, a subsidiary of Shire plc (SHPG) recently announced that it has entered into a settlement agreement with Anchen ...
  43. Nasdaq Stocks, Including Baidu, Making Big Moves on August 21, ...

    August 21, 2012
    After this morning's trading, the Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.3% and the Dow has ...
  44. Strong Quarter at Shire - Analyst Blog

    August 2, 2012
    Shire plc (SHPG) posted second-quarter 2012 earnings (excluding special items) of $1.68 per American Depositary Share (ADS), ...
  45. 46 Amusing ETF Ticker Symbols

    July 17, 2012
    Over the last few years, issuers have been waging their own little war in the ETF industry: the battle of the ticker symbol. ...
  46. Hi-Tech Pharmacal An Under Followed Name Worth Following

    July 12, 2012
    Hi-Tech Pharmacal gets little attention, but maybe it should.
  47. Be Greedy In Europe

    May 31, 2012
    The debt crisis in Europe makes it understandable why investors have ignored it. But the region’s current valuations make ...
  48. New Ratings: FB, SUPN, SDR, TLYS, EVER

    May 29, 2012
    New York, May 29th (TradersHuddle.com) - These are the research analyst new ratings before the market open. Facebook (NASDAQ:FB) ...
  49. One Man's Trash Is Another Man's Dividend Check

    May 24, 2012
    While it is a dirty job, the waste management industry could be exactly what a portfolio needs in this time of low interest ...
  50. Aceto Looking At A Tough Future

    May 15, 2012
    Aceto is making sound moves, but the results need to be better.
  51. Covidien Reports, Ready To Spin Off Pharma

    May 4, 2012
    Covidien is looking to bridge its current valuation discount with a number of purer-play rivals.
  52. High-Growth Small Caps With Short, Bullish Trends

    April 10, 2012
    We screened for small-cap stocks, with market caps below $1 billion. We then screened these names for those with high growth, ...
  53. Growth Stocks Not Necessarily Risky

    March 8, 2012
    By looking at growth and value investment as two sides of the same coin, growth stocks like Disney aren't neccessarily risky ...
  54. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

    March 6, 2012
    Several states have already slashed birth control subsidies. Learn how this will affect pharmaceutical stocks.
  55. Stocks And ETFs For An Undervalued Europe

    January 25, 2012
    Here are some ETFs and stocks that are undervalued and based in Europe.
  56. Sanofi's Investment Prospects

    December 21, 2011
    Sanofi has emerged as an unheralded value in pharmaceuticals.
  57. An Opportunity To Unmask Avon’s Beauty

    December 16, 2011
    The removal of Andrea Jung as CEO offers Avon a great opportunity to find a leader who can boost profits.
  58. 2 Top Hedges Against Europe's Collapse

    December 1, 2011
    If you’re interested, it’s iime to trade deep into European woes, writes Doug Fabian of ETF Trader. The news out of Europe ...
  59. Solazyme May Pay Off On Green Dreams

    November 10, 2011
    Solazyme may have an early lead in the biofuel race.
  60. Breaking Down European ETFs

    November 10, 2011
    Looking at the European ETFs in 2011.
  61. Biogen Idec Has Built A Valuable Franchise

    November 1, 2011
    Biogen Idec is a go-to name in MS that carries a lot of value. A credible buy for those with longer horizons.
  62. VCA Antech Cut Down To Value

    October 31, 2011
    Once a go-go growth stock, a more reasonable valuation may give this stock new life.
  63. Tupperware’s Direct Growth Potential

    October 28, 2011
    Tupperware's third quarter results offered the most recent illustration that growth potential is wide open across the world. ...
  64. The Contrarian Play In Europe

    October 26, 2011
    Nothing could be bolder than adding European stocks to a portfolio. Europe offers a fertile ground for contrarian investors. ...
  65. The Big Play In Pollution Control

    October 6, 2011
    As the world grapples with growing pollution and environmental concerns, the mitigation industry stands to profit. For investors, ...
  66. Betting On Healthcare's Growth Engine

    August 17, 2011
    In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors. ...
  67. Value To Be Had In Europe

    August 11, 2011
    The recent market rout has giving investors a chance to purchase quality European equities at cheaper prices.
  68. 3 Reasons To Own Veolia Environnement

    August 5, 2011
    This French large-cap is incredibly diversified both by lines of business and geography. I'll look at three reasons why now's ...
  69. Teva And Mylan Show Some Value Remains In Generics

    August 4, 2011
    These two generics companies seem to be heading in opposite directions, but the values are similar.
  70. New Oriental Not Too Cool For School

    July 19, 2011
    New Oriental is richly valued, but it's growing incredibly quick.
  71. Should Investors Circle Back To Cubist?

    July 19, 2011
    Cubist is hitting its targets, but it needs a more exciting pipeline.
  72. Best Funds For The Long Haul

    July 10, 2011
    Indexing doesn't just mean plopping your money into the S&P 500, money manager Tom Posey tells Kate Stalter in today's ...
  73. The Best Of Both Worlds With The TICK

    July 5, 2011
    The TICK blends the best of both the developed and developing nations.
  74. The Best IPOs From The First Half

    July 5, 2011
    The swarm of IPO activity that has graced the market in the first half of the year has injected major league cash into some ...
  75. Not Your Normal Alternative Energy Stocks

    June 27, 2011
    Learn about four recent IPOs that have become the new alternative energy plays.
  76. The Winner And Losers Of Recent IPOs

    June 13, 2011
    Learn the short-term fate of these 2011 IPOs.
  77. Lipitor: Pfizer's Loss Is Watson's Gain

    June 10, 2011
    With Lipitor coming off its patent soon, there are a couple of drug companies looking to cash in on sales of the generic ...
  78. More Options For Income

    June 8, 2011
    With replacing lost income on the minds of many retiring Baby Boomers, the options for dividend focused investing continue ...
  79. Teva And Cephalon Solve Each Other's Problems

    May 4, 2011
    Teva's acquisition of Cephalon is a logical deal that solves problems for each company.
  80. Finding The Green In Garbage

    April 28, 2011
    With higher commodities prices here to stay, companies that provide recycling and waste-to-energy applications will be big ...
  81. J&J Beats Analyst Expections, But Not Its Rivals

    April 25, 2011
    Tangible signs of sustained sales growth and consistent profit expansion are still absent at J&J.
  82. Embracing Tech With Israel

    April 13, 2011
    Israel is an emerging tech giant that could give the U.S. a run for its money, in the near future.
  83. Diamond Hill Continues To Grow

    March 25, 2011
    The investment advisor continues to pile on the assets. Here's why investors should care.
  84. Investing In Tech Through Emerging Markets

    March 23, 2011
    Moving beyond low-cost production foundries, many emerging markets such as israel, South Korea and Taiwan are experiencing ...
  85. Noah Holdings Brings Wealth Management To China

    March 21, 2011
    As the Chinese become wealthier, the need for wealth management and investment advisory services will also increase. Noah ...
  86. Second-Generation Biofuels Ready To Take Off

    February 24, 2011
    New biofuel companies hope to overcome the problems caused by corn-based ethanol by using innovative feed stocks.
  87. Risk With Little Reward At Johnson & Johnson

    January 27, 2011
    A number of Johnson & Johnson rivals trade at equally appealing valuations and have their acts together in terms of product ...
  88. U.K. A Value Bet Amid Euro Debt Crisis

    January 20, 2011
    The ongoing financial crisis in the European Union has made the United Kingdom a promising prospect for value investors. ...
  89. Soros' Top Picks

    January 12, 2011
    We take a peek at some of Soros Fund Management's top holdings to see what stocks George Soros has selected.
  90. Exploring Israel's Energy Potential

    January 7, 2011
    Israel recently made a major natural gas discovery. Find out how it will affect the industry.
  91. Options For Investing In Italy

    December 8, 2010
    The PIIGS nations embody the worst of the region. However, there may be some value left in Italy.
  92. Expected Increase In Research And Development

    November 8, 2010
    Research & Development (R&D) is the key to success in the pharmaceutical industry, but just how much of an impact ...
  93. Alternative Ways To Play The Marcellus Shale

    October 27, 2010
    As America searches for energy independence, natural gas consumption will increase.
  94. Invest In The Lip Balm Portfolio

    October 5, 2010
    Themed portfolios can often exceed established ones in performance - and the lip balm portfolio is just one example.
  95. Another Setback For Roche Is Bad News For ImmunoGen

    August 27, 2010
    Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.
  96. Finding Gold In Garbage

    August 19, 2010
    While it is a dirty job, the waste management industry could be exactly what a portfolio needs in this time uncertainty. ...
  97. Investing In Israel

    July 29, 2010
    Israel offers solid fundamentals with the high-growth potential of a tech economy.
  98. Free Cash Flow Yields Are Rising

    July 12, 2010
    What does free cash flow yield growth between 2005-2009 for these companies really mean for investors?
  99. Battery-Powered Car Stocks Gaining Momentum

    June 30, 2010
    With Tesla's new IPO the battery-powered car is gaining hype and momentum. Should you get on board, or take a peek under ...
  100. Covidien Shuffles The Deck

    June 1, 2010
    Covidien made a surprising deal to get into peripheral vascular therapies - a business with big growth potential.
  • Showing 1-100 of 117 items
  • 1
  • 2
  • >>
Trading Center